Aging and ovariectomy cause a decrease in brain glucose consumption in vivo in Wistar rats;El envejecimiento y la ovariectomía causan una disminución del consumo cerebral de glucosa in vivo en ratas Wistar

Revista Espanola de Geriatria y Gerontologia

Volumn 45, Issue 3, 2010, Pages 136-140

  López Grueso, Raúl ^a   Borrás, Consuelo ^a   Gambini, Juan ^a   Viña, José ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Aging; Cerebral Metabolism; Estrogens; Females; Positron emission tomography

Indexed keywords

ESTROGEN; FLUORODEOXYGLUCOSE F 18; GLUCOSE;

AGING; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE INTAKE; IN VIVO STUDY; LONGEVITY; NONHUMAN; OVARIECTOMY; POSITRON EMISSION TOMOGRAPHY; RAT; SEX DIFFERENCE; SHAM PROCEDURE; WISTAR RAT;

EID: 77951624019     PISSN: 0211139X     EISSN: 15781747     Source Type: Journal    
DOI: 10.1016/j.regg.2009.12.005     Document Type: Article

References (35)

1. Borrás C., Sastre J., García-Sala D., Lloret A., Pallardó F.V., and Viña J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 34 (2003) 546-552
2. Fernández-Ballesteros R, Díez-Nicolás J, Ruíz-Torres A. Spain Aging in Europe. En: Schroots J, Fernández Ballesteros R, Rudinger G, editores. IOS Press, Amsterdam, Berlín, Oxford, Tokyo, Washington DC. 1999; 107 - 121.
3. Viña J., Sastre J., Pallardó F., and Borrás C. Mitochondrial theory of aging: Importance to explain why females live longer than males. Antioxid Redox Signal 5 (2003) 549-556
4. Viña J., Borrás C., Gambini J., Sastre J., and Pallardó F.V. Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett 579 (2005) 2541-2545
5. Viña J., Borrás C., Gambini J., Sastre J., and Pallardó F.V. Why females live longer than males: Control of longevity by sex hormones. Sci Aging Knowledge Environ 23 (2005) pe17
6. Viña J., Sastre J., Pallardó F.V., Gambini J., and Borrás C. Role of mitochondrial oxidative stress to explain the different longevity between genders: Protective effect of estrogens. Free Radic Res 40 (2006) 1359-1365
7. Borras C., Gambini J., and Vina J. Mitochondrial oxidant generation is involved in determining why females live longer than males. Front Biosci 12 (2007) 1008-1013
8. Viña J., Sastre J., Pallardó F.V., Gambini J., and Borrás C. Modulation of longevity-associated genes by estrogens or phytoestrogens. Biol Chem 389 (2008) 273-277
9. Kushner M., Tobin M., Alavi A., Chawluk J., Rosen M., Fazekas F., et al. Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET. J Nucl Med 28 (1987) 1667-1670
10. Loessner A., Alavi A., Lewandrowski K.U., Mozley D., Souder E., and Gur R.E. Regional cerebral function determined by FDG-PET in healthy volunteers: Normal patterns and changes with age. J Nucl Med 36 (1995) 1141-1149
11. Ishii K., Sasaki M., Kitagaki H., Yamaji S., Sakamoto S., Matsuda K., et al. Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med 38 (1997) 925-928
12. Garraux G., Salmon E., Dequeldre C., Lemaire C., Laureys S., and Franck G. Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia. Neuroimage 10 (1999) 149-162
13. Mosconi L., Perani D., Sorbi S., Herholz K., Nacmias B., Holthoff V., et al. MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET. Neurology 63 (2004) 2332-2340
14. Pardo J.V., Lee J.T., Sheikh S.A., Surerus-Johnson C., Shah H., Munch K.R., et al. Where the brain grows old: Decline in anterior cingulate and medial prefrontal function with normal aging. Neuroimage 35 (2007) 1231-1237
15. Mosconi L., De Santi S., Li J., Tsui W.H., Li Y., Boppana M., et al. Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiology of Aging 29 (2008) 676-692
16. Driscoll I., Howard S.R., Stone J.C., Monfils M.H., Tomanek B., Brooks W.M., et al. The aging hippocampus: A multi-level analysis in the rat. Neuroscience 139 (2006) 1173-1185
17. Borrás C., Stvolinsky S., López-Grueso R., Fedorova T., Gambini J., Boldyrev A., et al. Low in vivo brain glucose consumption and high oxidative stress in accelerated aging. FEBS Lett 583 (2009) 2287-2293
18. Beason-Held L.L., Kraut M.A., and ResnickI S.M. Longitudinal changes in aging brain function. Neurobiol Aging 29 (2008) 483-496
19. Beason-Held L.L., Kraut M.A., and ResnickII S.M. Temporal patterns of longitudinal change in aging brain function. Neurobiol Aging 29 (2008) 497-513
20. De León M.J., Convit A., Wolf O.T., Tarshish C.Y., De Santi S., Rusinek H., et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET). Proc Natl AcadSci USA 98 (2001) 10966-10971
21. Mosconi L., De Santi S., Li J., Tsui W.H., Li Y., Boppana M., et al. Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging 29 (2008) 676-692
22. Yanase D., Matsunari I., Yajima K., Chen W., Fujikawa A., Nishimura S., et al. Brain FDG PET study of normal aging in Japanese: Effect of atrophy correction. Eur J Nucl Med Mol Imaging 32 (2005) 794-805
23. Small G.W., Kepe V., Ercoli L.M., Siddarth P., Bookheimer S.Y., Miller K.J., et al. PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 355 (2006) 2652-2663
24. Kepe V., Barrio J.R., Huang S.C., Ercoli L., Siddarth P., Shoghi-Jadid K., et al. Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proc Natl Acad Sci U S A 103 (2006) 702-707
25. Mosconi L., Brys M., Switalski R., Mistur R., Glodzik L., Pirraglia E., et al. Maternal family history of Alzheimer′s disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci USA 104 (2007) 19067-19072
26. Mosconi L., Mistur R., Switalski R., Brys M., Glodzik L., Rich K., et al. Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology 72 (2009) 513-520
27. Hamacher K., Coenen H.H., and Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27 (1986) 235-238
28. Phelps M.E., Huang S.C., Hoffman E.J., Selin C., Sokoloff L., and Kuhl D.E. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method. Ann Neurol 6 (1979) 371-388
29. Huang S.C., Phelps M.E., Hoffman E.J., Sideris K., Selin C.J., and Kuhl D.E. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 238 (1986) E69-E82
30. Yamaji S., Ishii K., Sasaki M., Mori T., Kitagaki H., Sakamoto S., et al. Evaluation of standardized uptake value to assess cerebral glucose metabolism. Clin Nucl Med 25 (2000) 11-16
31. Keyes Jr. J.W. SUV: Standard uptake or silly useless value?. J Nucl Med 36 (1995) 1836-1839
32. Fueger B.J., Czernin J., Hildebrandt I., Tran C., Halpern B.S., Stout D., et al. Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med 47 (2006) 999-1006
33. Schiffer W.K., Mirrione M.M., and Dewey S.L. Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents. J Nucl Med 48 (2007) 277-287
34. De León M.J., Mosconi L., and Logan J. Seeing what Alzheimer saw. Nat Med 13 (2007) 129-131
35. Rasgon N.L., Silverman D., Siddarth P., Miller K., Ercoli L.M., Elman S., et al. Estrogen use and brain metabolic change in postmenopausal women. Neurobiol Aging 26 (2005) 209-235